BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 32984059)

  • 1. Dysregulated Phosphorylation of p53, Autophagy and Stemness Attributes the Mutant p53 Harboring Colon Cancer Cells Impaired Sensitivity to Oxaliplatin.
    Therachiyil L; Haroon J; Sahir F; Siveen KS; Uddin S; Kulinski M; Buddenkotte J; Steinhoff M; Krishnankutty R
    Front Oncol; 2020; 10():1744. PubMed ID: 32984059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reactivating p53 and Inducing Tumor Apoptosis (RITA) Enhances the Response of RITA-Sensitive Colorectal Cancer Cells to Chemotherapeutic Agents 5-Fluorouracil and Oxaliplatin.
    Wiegering A; Matthes N; Mühling B; Koospal M; Quenzer A; Peter S; Germer CT; Linnebacher M; Otto C
    Neoplasia; 2017 Apr; 19(4):301-309. PubMed ID: 28284059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TRIM29 Reverses Oxaliplatin Resistance of P53 Mutant Colon Cancer Cell.
    Lei G; Liu S; Yang X; He C
    Can J Gastroenterol Hepatol; 2021; 2021():8870907. PubMed ID: 33824865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Curcumin causes superoxide anion production and p53-independent apoptosis in human colon cancer cells.
    Watson JL; Hill R; Yaffe PB; Greenshields A; Walsh M; Lee PW; Giacomantonio CA; Hoskin DW
    Cancer Lett; 2010 Nov; 297(1):1-8. PubMed ID: 20472336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perifosine enhances the potential antitumor effect of 5-fluorourasil and oxaliplatin in colon cancer cells harboring the PIK3CA mutation.
    Morii Y; Tsubaki M; Takeda T; Otubo R; Seki S; Yamatomo Y; Imano M; Satou T; Shimomura K; Nishida S
    Eur J Pharmacol; 2021 May; 898():173957. PubMed ID: 33662352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cepharanthine exhibits a potent anticancer activity in p53-mutated colorectal cancer cells through upregulation of p21Waf1/Cip1.
    Rattanawong A; Payon V; Limpanasittikul W; Boonkrai C; Mutirangura A; Wonganan P
    Oncol Rep; 2018 Jan; 39(1):227-238. PubMed ID: 29138869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. P53-mediated upregulation of DcR1 impairs oxaliplatin/TRAIL-induced synergistic anti-tumour potential in colon cancer cells.
    Toscano F; Fajoui ZE; Gay F; Lalaoui N; Parmentier B; Chayvialle JA; Scoazec JY; Micheau O; Abello J; Saurin JC
    Oncogene; 2008 Jul; 27(30):4161-71. PubMed ID: 18345033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxaliplatin-loaded nanoemulsion containing
    Al-Otaibi WA; AlMotwaa SM
    Drug Deliv; 2022 Dec; 29(1):2190-2205. PubMed ID: 35815706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-338-3p confers 5-fluorouracil resistance in p53 mutant colon cancer cells by targeting the mammalian target of rapamycin.
    Han J; Li J; Tang K; Zhang H; Guo B; Hou N; Huang C
    Exp Cell Res; 2017 Nov; 360(2):328-336. PubMed ID: 28928082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemosensitivity of human colon cancer cells is influenced by a p53-dependent enhancement of ceramide synthase 5 and induction of autophagy.
    Brachtendorf S; Wanger RA; Birod K; Thomas D; Trautmann S; Wegner MS; Fuhrmann DC; Brüne B; Geisslinger G; Grösch S
    Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Oct; 1863(10):1214-1227. PubMed ID: 30059758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergy between histone deacetylase inhibitors and DNA-damaging agents is mediated by histone deacetylase 2 in colorectal cancer.
    Alzoubi S; Brody L; Rahman S; Mahul-Mellier AL; Mercado N; Ito K; El-Bahrawy M; Silver A; Boobis A; Bell JD; Hajji N
    Oncotarget; 2016 Jul; 7(28):44505-44521. PubMed ID: 27283986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of autophagy exerts anti-colon cancer effects via apoptosis induced by p53 activation and ER stress.
    Sakitani K; Hirata Y; Hikiba Y; Hayakawa Y; Ihara S; Suzuki H; Suzuki N; Serizawa T; Kinoshita H; Sakamoto K; Nakagawa H; Tateishi K; Maeda S; Ikenoue T; Kawazu S; Koike K
    BMC Cancer; 2015 Oct; 15():795. PubMed ID: 26496833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. JNK confers 5-fluorouracil resistance in p53-deficient and mutant p53-expressing colon cancer cells by inducing survival autophagy.
    Sui X; Kong N; Wang X; Fang Y; Hu X; Xu Y; Chen W; Wang K; Li D; Jin W; Lou F; Zheng Y; Hu H; Gong L; Zhou X; Pan H; Han W
    Sci Rep; 2014 Apr; 4():4694. PubMed ID: 24733045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53 dependent and independent sensitivity to oxaliplatin of colon cancer cells.
    Toscano F; Parmentier B; Fajoui ZE; Estornes Y; Chayvialle JA; Saurin JC; Abello J
    Biochem Pharmacol; 2007 Aug; 74(3):392-406. PubMed ID: 17559811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. KIF11 is upregulated in colorectal cancer and silencing of it impairs tumor growth and sensitizes colorectal cancer cells to oxaliplatin via p53/GSK3β signaling.
    Zhou Y; Yang L; Xiong L; Wang K; Hou X; Li Q; Kong F; Liu X; He J
    J Cancer; 2021; 12(12):3741-3753. PubMed ID: 33995648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-proliferative and apoptotic effect of gemini curcumin in p53-wild type and p53-mutant colorectal cancer cell lines.
    Ebrahimi M; Babaei E; Neri F; Feizi MAH
    Int J Pharm; 2021 May; 601():120592. PubMed ID: 33857585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The inhibition of autophagy sensitises colon cancer cells with wild-type p53 but not mutant p53 to topotecan treatment.
    Li DD; Sun T; Wu XQ; Chen SP; Deng R; Jiang S; Feng GK; Pan JX; Zhang XS; Zeng YX; Zhu XF
    PLoS One; 2012; 7(9):e45058. PubMed ID: 23024792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticancer efficacy of hirsuteine against colorectal cancer by opposite modulation of wild-type and mutant p53.
    Zhang Y; Guo T; Li S; Ren Z; Gao S; Lu H; Ma X; Liu D; Liu Y; Kong D; Qiu Y
    Discov Oncol; 2023 May; 14(1):84. PubMed ID: 37256374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of AXL in invasion and drug resistance of colon and breast cancer cells and its association with p53 alterations.
    Abdel-Rahman WM; Al-Khayyal NA; Nair VA; Aravind SR; Saber-Ayad M
    World J Gastroenterol; 2017 May; 23(19):3440-3448. PubMed ID: 28596680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of functional p53 renders DENSpm-induced autophagy and apoptosis in time dependent manner in colon cancer cells.
    Çoker-Gürkan A; Arisan ED; Obakan P; Palavan-Unsal N
    Amino Acids; 2015 Jan; 47(1):87-100. PubMed ID: 25311224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.